UNION CITY, Calif.,
Sept. 13, 2012 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, announced today
that Clint Severson, chairman and
chief executive officer, will present at the UBS Global Life
Sciences Conference on Wednesday, September
19, 2012 at 10:00 a.m. ET. The
conference will be held at the Grand Hyatt New York Hotel in
New York City.
About Abaxis
Abaxis develops, manufactures, markets and sells portable
blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system
can be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system
provides test results in less than 12 minutes with the precision
and accuracy equivalent to a clinical laboratory analyzer. The
veterinary business also provides to the animal health and research
market a line of hematology instruments for point-of-care complete
blood counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fibrinogen levels, a
handheld instrument for the rapid assessment of certain critical
care tests and rapid point-of-care tests for Heartworm infections,
Parvovirus, Giardia and Lyme disease. Abaxis, through its AVRL
division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.
Contact:
|
Clint
Severson
|
Lytham
Partners, LLC
|
|
Chief
Executive Officer
|
Joe
Dorame, Joe Diaz & Robert Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
SOURCE Abaxis, Inc.